Biocon stock gains over 1% as Biocon Biologics partner Viatris wins US court decisions on Sanofi appeals for Lantus Device Patents

The U.S. Court of Appeals for the Federal Circuit (USCAFC) has upheld the U.S. Patent and Trademark Appeal Board’s decisions for unpatentability of five device patents for Sanofi’s Lantus SoloSTAR.

Related Keywords

United States ,New Jersey ,Americans ,Sanofi Lantus Solo ,Shreehas Tambe ,Biocon Biologics ,Trademark Office ,Biocon Biologics Ltd ,Biocon ,Us Court ,Us District Court ,Federal Circuit ,Trademark Appeal Board ,Patent Trial ,Appellate Board ,Sanofi Lantus ,